Characterization of the embB gene in Mycobacterium tuberculosis isolates from barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 947-954

  Moure, Raquel ^a   Español, Montserrat ^b   Tudó, Griselda ^c   Vicente, Eva ^d   Coll, Pere ^b   Gonzalez Martin, Julian ^c   Mick, Virginie ^e   Salvadó, Margarita ^d   Alcaide, Fernando ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d Laboratori de Referencia de Catalunya   (Spain)

^e ANSES   (France)

Author keywords

Antituberculous resistance; Microarrays; Molecular diagnosis; Tuberculosis

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATION; CODON; CONTROLLED STUDY; DNA DETERMINATION; EMBB GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULOUS RESISTANCE; MICROARRAYS; MOLECULAR DIAGNOSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CODON; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; GENOTYPE; HUMANS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PENTOSYLTRANSFERASES; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 84896457240     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt448     Document Type: Article

References (28)

1. WHO.Treatment of Tuberculosis Guidelines. 4thedn.Geneva,Switzerland: WHO, 2010.
2. Mikusova K, Slayden RA, Besra GS et al. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 1995; 39: 2484-9.
3. Takayama K, Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 1989; 33: 1493-9.
4. WHO. Anti-Tuberculosis Drug Resistance in the World. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva, Switzerland: WHO, 2010.
5. Telenti A, Philipp WJ, Sreevatsan S et al. Theemboperon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997; 3: 567-70.
6. Alcaide F, Pfyffer GE, Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 1997; 41: 2270-3.
7. Ahmad S, Jaber AA, Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinb) 2007; 87: 123-9.
8. Plinke C, Rusch-Gerdes S, Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2006; 50: 1900-2.
9. Safi H, Sayers B, Hazbon MH et al. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 2008; 52: 2027-34.
10. Sreevatsan S, Stockbauer KE, Pan X et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-81.
11. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J ClinMicrobiol 2009; 47: 1767-72.
12. Johnson R, Jordaan AM, Pretorius L et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006; 10: 68-73.
13. Shen X, Shen GM, Wu J et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 2618-20.
14. Hazbon MH, del Bobadilla V, Guerrero MI et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-802.
15. Parsons LM, Salfinger M, Clobridge A et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazidandethambutol.AntimicrobAgentsChemother2005;49:2218-25.
16. Ramaswamy SV, Amin AG, Goksel S et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 326-36.
17. Safi H, Fleischmann RD, Peterson SN et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance toethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2010; 54: 103-8.
18. Lee AS, Othman SN, Ho YM et al. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48: 4447-9.
19. Mokrousov I, Otten T, Vyshnevskiy B et al. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J Clin Microbiol 2002; 40: 3810-3.
20. Perdigao J, Macedo R, Ribeiro A et al. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents 2009; 33: 334-8.
21. Ramaswamy SV, Dou SJ, Rendon A et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004; 53: 107-13.
22. Srivastava S, Garg A, Ayyagari A et al. Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. Curr Microbiol 2006; 53: 401-5.
23. Gryadunov D, Mikhailovich V, Lapa S et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2005; 11: 531-9.
24. Tang X, Morris SL, Langone JJ et al. Microarray and allele specific PCR detection of point mutations in Mycobacterium tuberculosis genes associated with drug resistance. J Microbiol Methods 2005; 63: 318-30.
25. Aragon LM, Navarro F, Heiser V et al. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J Antimicrob Chemother 2006; 57: 825-31.
26. Moure R, Tudó G, Medina R et al. Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array. Tuberculosis (Edinb) 2013; 93: 508-14.
27. Supply P, Allix C, Lesjean S et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 4498-510.
28. Fortun J, Martin-Davila P, Navas E et al. Changes in the epidemiology of tuberculosis: the influence of international migration flows. Enferm Infecc Microbiol Clin 2011; 29: 654-9.